公司資料
TELA Bio 股價、新聞與催化劑
- 股票代碼:
- TELA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.65 USD (+1.09%)
收盤價
最後更新: 2026年8月21日
40.7M USD
市值
股價為何變動
As of Aug 21, 2026, TELA closed up 1.09% at $0.6463. No new same-company headline was identified in the current news window.
公司概覽
Soft-Tissue Reconstruction Company
TELA Bio develops medical devices for hernia repair, abdominal-wall reconstruction, and plastic and reconstructive surgery.
Reinforced Tissue Matrices
The OviTex portfolio combines biologic tissue with polymer reinforcement to provide strength while supporting tissue remodeling.
Commercial Surgical Model
TELA sells through a specialized surgical sales force and is expanding internationally as additional surgeons adopt its tissue-reconstruction products.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。
